Ohio s Medical Marijuana Control Program

Similar documents
Ohio Medical Marijuana Control Program

From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016

The Legalization of Medical Marijuana and the Impact on the Workplace

Substitute HB 523 Outline

Workplace Issues Associated with Legalized Marijuana. James B. Yates, Esq., SHRM-SCP, SPHR

MEDICAL MARIJUANA: Can Cannabis Still Get You Canned?

Medical Marijuana Update

Weeding Through the Workplace Impact of Medical Marijuana

The Department must establish a minimum of three regions within the state for the purpose of granting permits to growers/processors and dispensaries.

ASSEMBLY APPROPRIATIONS COMMITTEE STATEMENT TO. ASSEMBLY COMMITTEE SUBSTITUTE FOR ASSEMBLY, No STATE OF NEW JERSEY DATED: APRIL 5, 2018

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1

Pennsylvania s Medical Marijuana Act and the Creation of a New Protected Class of Employees. Agenda

The public comment period for form and method of administration rules is now closed. There will be additional opportunities to provide public comment

Pennsylvania s Medical Marijuana Act. William Roark, Esq. HRMM&L

Arkansas Municipal League. What Cities Need to Know about the Arkansas Medical Marijuana Amendment

North Central Florida Regional Planning Council

Medical Marijuana Update Chris Belletieri, DO

Medical Marijuana: Coverage Considerations for the Buckeye State. ISCEBS & CSHRM Education Session April 20, 2018

Medical Cannabis Ordinances. Tuesday, December 20, 2016

Maine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014

MEMORANDUM. DATE: November 19, Senator Kohl-Welles. Kathleen Buchli, Counsel medical marijuana proposal

Understanding Maine s Medical Marijuana Law

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018

Bulletin August, 2016 MEDICAL MARIJUANA

12/19/2017. Medical Marijuana on Campus: Employment and Student Conduct Implications. Without getting into the weeds. Scheduling

Insight. Marijuana Legalization Efforts Enjoy Success, Demonstrating Major Shift in Approach to Drug Regulation and Use NOVEMBER 9, 2016

MINNESOTA S MEDICAL CANNABIS PROGRAM

MEMORANDUM INTRODUCTION. DATE: July 28, 2016; Revised August 3, 2016 TO:

Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014

Be it enacted by the People of the State of Illinois,

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

EDIBLE CANNABIS STATE REGULATIONS. Karmen Hanson, MA- Health Program

The West Virginia Medical Cannabis Act

Pennsylvania s Medical Marijuana Program

Did you know. Getting Started. Intoxication and Workers Compensation Claims

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

RESOLUTION NO A RESOLUTION APPROVING REFERRAL TO THE ELECTORS OF THE CITY OF ALBANY THE

Coordinated Student Health Services. Medical Marijuana/ Low THC Cannabis Use To Qualified Students In Schools Policy

City of Coral Gables Planning and Zoning Staff Recommendation

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace

Background. Ohio s New Medical Marijuana Law and Its Impact on Townships. Overview 4/24/2017. Susan M. Bungard Walter Haverfield, LLP

AZ s Medical Marijuana Law Overview and Considerations. Ryan Hurley Partner, Chair of MMJ Dept. Rose Law Group pc

Barbara Brohl Executive Director & State Licensing Authority Colorado Department of Revenue

December 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage

Minnesota Medical Cannabis Program. October 24, 2017

Legalization of Recreational Cannabis

Oregon Medical Marijuana Dispensary Program. Thomas A. Burns Director Pharmacy Programs Oregon Health Authority

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 1015 SUMMARY

MEDICAL MARIJUANA USE

Compassionate Medical Cannabis: What It Means to the Street Officer

THE STATE OF THE STATES-A REPORT ON MEDICAL CANNABIS PROGRAMS MID YEAR MEETING AND SCIENTIFIC SEMINAR APRIL 13, 2018 NASHVILLE, TENNESSEE DEBBY MIRAN

Policy \ \ Medical (Palliative) Use of Marijuana

The Straight Dope: Without getting into the weeds. Scheduling. Controlled Substances Act

Diane E. Hoffmann, J.D., M.S. University of Maryland School of Law

Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction

INITIAL PATIENT INTAKE FORM

City Commission Agenda Cover Memorandum

Susan Audino, PhD S.A. Audino & Associates, LLC

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Proposition 64 Adult Use Marijuana Act (AUMA) with Information on Medical Cannabis

ORDINANCE NO

Marijuana Legalization: Issues and Questions for Municipalities Lincoln County Regional Planning Commission January 25, 2017

MEDICAL CANNABIS IN MINNESOTA

Guidance for Municipalities Regarding Marijuana for Adult Use January 2018

MEDICAL CANNABIS IN MINNESOTA

MORICONI FLOWERS LTD.

An HR Perspective: Medical Marijuana and How it Affects Employers

MEDICAL MARIJUANA AND HEALTH CARE FACILITIES

CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 1030

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Q & A With MPP s Rob Kampia Regarding the 2016 Ohio Medical Marijuana Initiative

House Economic Development Committee Medical Cannabis Overview

CALIFORNIA AND MEDICAL MARIJUANA

78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 964 SUMMARY

Senator Mark B. Madsen proposes the following substitute bill:

Policy / Drug and Alcohol-Free Workshops

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL AN ACT

Frequently Asked Questions

IMPLICATIONS FOR MEDICAL MARIJUANA LEGALIZATION IN OHIO

ARIZONA MEDICAL MARIJUANA PROGRAM. Tina Wesoloskie, MPA Office of Medical Marijuana Card Registry Arizona Department of Health Services

Marijuana Legalization Update

Legal Licensing and Compliance in the Commercial Cannabis Industry

COLERAIN TOWNSHIP ZONING COMMISSION Regular Meeting Tuesday, April 17-6:00 p.m.

Please note that this draft is incomplete and likely to change before and/or after City Planning Commission review.

Medical Marijuana Legalization and the Impact on Colorado s Counties. CCAP Workshop

ENROLLED 2014 Legislature CS for CS for SB 1030, 1st Engrossed

78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled

TEXAS COMPASSIONATE-USE ACT

HR UP IN SMOKE: THE INTERSECTION BETWEEN MARIJUANA LEGALIZATION AND EMPLOYMENT LAW. Michigan Municipal League

Pennsylvania s Medical Marijuana Program

Use of Cannabinoids in Medical Practice

Community Meeting: Local Cannabis Policy in Oroville

THE EFFECTS OF MEDICAL MARIJUANA IN THE WORKPLACE

The Status of the Marijuana Industry and What Attorneys Need to Know When Representing Cannabis Clients. June 2017

House Bill 2198 Ordered by the House July 1 Including House Amendments dated June 2 and July 1

Transcription:

Ohio s Medical Marijuana Control Program

Timeline September 8, 2016 House Bill 523 Effective November 5, 2016 Deadline for first Medical Marijuana Advisory Committee meeting May 6, 2017 Cultivator rules adopted September 8, 2017 All other rules adopted September 8, 2018 Ohio Medical Marijuana Control Program operational

Who is Responsible? Department of Commerce Cultivators Processors Testing laboratories State Board of Pharmacy Dispensaries Patients/Caregivers New forms and methods of medical marijuana Medical Board Certified physicians New qualifying conditions

Medical Marijuana Process Flow Chart Cultivators Processors Dispensaries Patients Physicians Testing Lab Testing Lab

Role of the Department of Commerce

Cultivators When drafting the regulations, the MMCP balanced the cost of compliance with the benefit of the regulation. The MMCP created two levels of cultivator licenses based on the feedback received from many different stakeholders, and these licenses have the ability to expand to meet demand. The MMCP identified the need for a plant-only processor license to allow for direct shipment of plant material from a cultivator to a dispensary.

Cultivator Final Rules Based on multiple rounds of public comment and feedback from the Common Sense Initiative, the JCARR filed cultivator rules: Removed the designated territories from Commerce s rule sets. Reduced the financial responsibility requirements to account for industry uncertainties. Limited tax documentation in the application to summary pages for any individual or entity with a 1% or greater financial interest. Revised the surveillance technology requirements to provide for motionactivated recording technology and a 45 day retention period. Established a review process for advertisements submitted to the Department.

Processors The O.R.C. 3796 establishes the approved forms and methods of administration for medical marijuana, and the processor rules accommodate the different methods used to manufacture these forms. Flexibility is important as new processes and methods surface as the market matures, as well as new forms are approved by the board. Set the annual license fee at an amount that reflects the plantonly processor license and the limited forms available at the Program s inception. A ceiling was set at 40 processor licenses to allow for vertical integration and greater product variety for patients.

Testing Laboratories Provides a mechanism to issue public university licenses and private laboratory licenses in accordance with H.B. 523. Offers testing flexibility at different points during the manufacturing process to eliminate redundancies, control costs, and ensure patient safety. Creates a universal standard for licensed labs that can accommodate future advancements in analytical techniques without departing from that standard.

Role of the State Board of Pharmacy

Pharmacy s Role in Rule Development Responsible for rules relating to: Registration of patients/caregivers Retail dispensaries Form and method of medical marijuana Authorized to: Enforce rules related to patients/caregivers and dispensaries Use Ohio Automated Rx Reporting System for the collection of information related to dispensing medical marijuana to registered patients Disseminate registered patient information to retail dispensaries

The Board may issue up to 60 dispensary licenses through a competitive selection process Dispensaries will be required to report to the Ohio Automated Rx Reporting System in real-time Dispensaries Employees will be required to be licensed with the Board and to wear Board-issued ID cards while on dispensary premises Dispensaries will have to develop a policy for the education of patients and caregivers Dispensaries will be required to pay a $5,000 application fee and $70,000 biennial licensing fee

All patients and caregivers must register with the Board to receive a state-issued medical marijuana patient identification card Patients and Caregivers o Registration will be electronic and can be submitted by a patients recommending physician or physician s delegate o Annual registration fee is $50 for patients and $25 for caregivers Patients under 18 must have a parent or legal representative as a caregiver A person must be 21 to serve as a caregiver and patient can have up to 2 caregivers; each caregiver can have up to 2 patients

House Bill 523-Approved Forms Oils Tinctures Plant material Edibles Patches

House Bill 523 Prohibitions on Form and Method of Administration Forms and methods considered attractive to children Forms that require smoking or combustion

Responsible for most of the psychoactive effects of cannabis THC Content Best available clinical data is for less than 23% THC o Data focuses on efficacy based on THC content o Does not take into account the Ensemble Effect (also known as the Entourage Effect) o Limited studies demonstrate this effect at this time

90-Day Supply of Plant Material Tier THC Content Maximum 90-Day Supply THC Medical Efficacy Adverse Events Tier 1 0 23% 8 oz. 10 oz. (terminal exception) Tier 2 23.1 35% 5.3 oz. 6.6 oz. (terminal exception) + + +

90-Day supply of medical marijuana based on THC content Form Tier I plant material (up to 23% THC) Tier II plant material (over 23% THC) Oils for vaporizing Patches for transdermal administration Edibles, oils, and tinctures for oral administration 90-Day Supply 8 ounces of plant material; 10 ounces for terminal exception 5.3 ounces of plant material; 6.6 ounces for terminal exception 53.1 grams of THC; 65.7 grams for terminal exception 26.6 grams of THC; 33.3 grams for terminal exception 9.9 grams of THC; 11.7 grams for terminal exception

Role of the State Medical Board

Recommending v. Prescribing The Federal government prohibits doctors from being able to prescribe marijuana Patients must have a recommendation from a certified physician Interested physicians must apply for a certificate to recommend (CTR) from the State Medical Board The process to develop the CTR will be established in Medical Board rules Must be adopted by September 2017.

Qualifying Conditions The State Medical Board has statutory authority to create a petition process used to add, not remove, qualifying conditions. AIDS Amyotrophic Lateral Sclerosis Alzheimer s Disease Cancer Chronic Traumatic Encephalopathy Crohn s Disease Epilepsy / Seizure Disorder Fibromyalgia Glaucoma Hepatitis C Inflammatory Bowel Disease Multiple Sclerosis Pain: Chronic/Severe or Intractable Parkinson s Disease Positive Status for HIV Post-traumatic Stress Disorder Sickle Cell Anemia Spinal Cord Disease or Injury Tourette s Syndrome Traumatic Brain Injury Ulcerative Colitis

Physician interest 15% 3% 82% Respondents MD DO Other HOW LIKELY WOULD YOU BE TO RECOMMEND MEDICAL MARIJUANA TO A PATIENT WITH A QUALIFYING CONDITION? (PERCENT OF RESPONSES) Extremely Somewhat Neutral More than 3,000 licensees responded. There are approximately 46,000 physicians (MDs and DOs) currently licensed with the State Medical Board of Ohio. 17.37 15.55 11.21 26.05 12.28 17.54 Down 7% from the original survey in September. The difference shows up as in increase in the N/A category of respondents who indicated they do not manage patients with qualifying conditions. LIKELY UNLIKELY NEUTRAL N/A 22

MedicalMarijuana.Ohio.Gov Designed to keep Ohioans informed about the development of Ohio s Medical Marijuana Control Program Important timelines in the rule-making process Announcement of opportunities for public input